The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.40
Bid: 47.50
Ask: 48.10
Change: 0.60 (1.26%)
Spread: 0.60 (1.263%)
Open: 48.80
High: 48.80
Low: 47.90
Prev. Close: 47.80
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Award - Performance Share Plan

22 Nov 2019 15:00

RNS Number : 3960U
Renold PLC
22 November 2019
 

Renold plc

("Renold" or the "Group")

 

Grant of Award - Performance Share Plan

 

22 November 2019

 

Renold announces that its Chief Executive Officer, Robert Purcell, was today granted 1,834,862 nil cost options (the "Award") under the 2013 Performance Share Plan (the "Plan").

 

The number of shares granted under the Award has been calculated using an average share price of 32.7 pence per share.

 

The performance period applicable to the Award is for three years commencing on 1 April 2019. The Award will vest on 21 November 2022, subject to achievement of earnings per share performance conditions and the rules of the Plan.

 

The notification below, made in accordance with the requirements of Article 7 of the EU Market Abuse Regulation, provides further detail:

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Robert Purcell

2

Reason for the notification

 

a)

Position/Status

 

 

Chief Executive Officer

 

b)

Initial notification / amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

 

Renold Plc

 

b)

LEI

 

 

213800LNDGJY65SP6P54

4

Details of transactions(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 

 

GB0007325078

b)

Nature of the transaction

Grant of awards pursuant to the Company's 2013 performance share plan

c)

Price(s) and

Volume(s)

 

Price(s)

Volume(s)

Nil

1,834,862

d)

Aggregated

Information

 

Aggregated volume

 

Price

 

N/A

e)

Date of transaction

 

 

22 November 2019

f)

Place of transaction

 

 

Off market

 

 

 

ENQUIRIES:

Renold plc

Peel Hunt LLP

Instinctif Partners

Robert Purcell, CEO

Mike Bell

Mark Garraway

Ian Scapens, Group FD

Ed Allsopp

Rosie Driscoll

Tel: 0161 498 4500

Tel: 020 7418 8900

Tel: 020 7457 2020

 

 

NOTES FOR EDITORS

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, metals and mining.

 

Further information about Renold can be found on their website at: www.renold.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAFFAASANFFF
Date   Source Headline
15th Apr 20247:00 amRNSTrading update for the year ended 31 March 2024
4th Mar 20241:13 pmRNSHolding(s) in Company
16th Feb 20243:37 pmRNSHolding(s) in Company
5th Feb 20243:49 pmRNSHolding(s) in Company
1st Feb 20249:59 amRNSHolding(s) in Company
18th Jan 20243:41 pmRNSHolding(s) in Company
18th Jan 20243:40 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSBlock Listing Six Monthly Return
22nd Nov 20237:00 amRNSPreference Stock Dividend
20th Nov 20234:20 pmRNSHolding(s) in Company
16th Nov 20234:53 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSInterim Results
3rd Nov 20237:05 amRNSNotice of Results
5th Sep 20234:15 pmRNSResult of AGM
5th Sep 20237:00 amRNSAGM Trading Update
1st Sep 20237:00 amRNSAcquisition of Davidson Chain PTY
7th Aug 20239:00 amRNS2023 Annual Report and Accounts and 2023 AGM
2nd Aug 20232:21 pmRNSHolding(s) in Company
25th Jul 202312:15 pmRNSGrant of Options
12th Jul 20237:00 amRNSResults for the year ended 31 March 2023
10th Jul 20237:00 amRNSInvestor Presentation
19th Jun 20239:30 amRNSBlock Listing Six Monthly Return
18th May 20237:00 amRNSPreference Stock Dividend
9th May 20237:00 amRNSExtension of banking facilities
3rd May 202311:09 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
28th Mar 202312:53 pmRNSHolding(s) in Company
9th Mar 20237:00 amRNSNotice of Capital Markets Day
23rd Feb 202312:09 pmRNSHolding(s) in Company
10th Feb 20232:07 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSTrading Update
25th Jan 202310:00 amRNSHolding(s) in Company
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSContract Win
19th Dec 20227:00 amRNSBlock Listing Six Monthly Return
8th Dec 20227:00 amRNSHolding(s) in Company
24th Nov 20225:18 pmRNSPreference Stock Dividend
16th Nov 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
12th Oct 20229:12 amRNSHolding(s) in Company
5th Oct 20224:10 pmRNSHolding(s) in Company
20th Sep 202212:34 pmRNSGrant of Options
9th Sep 202211:37 amRNSDirector/PDMR Shareholding
6th Sep 202212:13 pmRNSResult of AGM
6th Sep 20227:00 amRNSAGM Trading Update
4th Aug 20227:30 amRNS2022 Annual Report & Notice of AGM
4th Aug 20227:00 amRNSAcquisition of Industrias YUK S.A.
13th Jul 20227:00 amRNSFinal results for the year ended 31 March 2022
8th Jul 20227:00 amRNSInvestor presentation
17th Jun 20227:00 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.